US FDA. DRAFT GUIDANCE. PROCEDURES FOR EVALUATING APPEARANCE ISSUES AND GRANTING AUTHORIZATIONS FOR PARTICIPATION IN FDA ADVISORY COMMITTEES. JUN 2016.